#United States #PAD #Audubon #AIROS Medical #ARTAIRA

AIROS Medical Unveils the ARTAIRA Compression Device

AIROS® Medical, Inc., a prominent name in the medical technology sector, has recently announced the launch of its ARTAIRA® Arterial Compression Device, which has received FDA 510(k) clearance. This state-of-the-art device is specifically designed to address the needs of patients experiencing symptoms of Peripheral Arterial Disease (PAD).

Addressing a Growing Health Concern

Peripheral Arterial Disease is becoming a critical health issue worldwide, with projections indicating a staggering 220% increase in the number of PAD cases by 2050, potentially affecting over 360 million individuals globally. PAD, characterized by the narrowing of arteries that restrict blood flow to the limbs, particularly the legs, can lead to debilitating symptoms, tissue death, infections, and in severe cases, amputation.

The ARTAIRA device is an innovative non-invasive tool that employs intermittent pneumatic compression to significantly enhance blood flow and circulation in the lower extremities. By allowing patients to receive care from the comfort of their homes, this device marks a significant advancement in the management of PAD.

How the ARTAIRA Device Works

At the core of the ARTAIRA's functionality are rapid, high-pressure compression cycles aimed at stimulating blood flow in the calf, ankle, and foot areas. The device utilizes two-chamber garments, one of which inflates behind the calf while the other interiorly inflates near the foot. This dual-chamber system applies a targeted pressure of 120 mmHg, effectively promoting circulation through a timed sequence of inflation and deflation.

Significance for Patients and Healthcare Providers

According to Darren M. Behuniak, Chief Operating Officer of AIROS Medical, the introduction of ARTAIRA comes at a pivotal time, particularly for aging populations and individuals with diabetes, who are at higher risk of suffering from PAD-related health complications. "Our focus has always been on enhancing patient outcomes. With ARTAIRA, we're taking our core expertise in lymphedema and chronic venous insufficiency and applying it to the wider issue of vascular disorders."

The lightweight, compact design of ARTAIRA makes it user-friendly, featuring a simple two-button interface and a large color LCD screen that displays both pressure and treatment duration information. Weighing just seven pounds, it is easy for patients to manage independently.

Affordability and Accessibility

The ARTAIRA device is now available throughout the United States and is covered by Medicare and several other health insurance plans when the necessary documentation is provided. This accessibility is a crucial factor, ensuring that patients who need it most can obtain this innovative tool without facing overwhelming financial burdens.

AIROS Medical plans to support the introduction of ARTAIRA via clinical education programs, workshops, and live demonstrations at various medical conferences focused on podiatry, vascular health, and wound care. These initiatives aim to educate both patients and healthcare providers about the benefits of this pioneering device.

Looking Ahead

As AIROS Medical expands its product line, the journey for improving patient mobility and quality of life continues. With a focus on delivering advanced compression therapy systems, the company is dedicated to meeting the increasing demand for effective, home-based treatments for peripheral vascular disorders. For more information about the ARTAIRA system and other vascular compression therapies, you can visit their official website at www.airosmedical.com.

In conclusion, AIROS Medical's ARTAIRA device represents a significant leap forward in the management of Peripheral Arterial Disease, providing vital support for millions of individuals at risk of severe health complications due to inadequate blood flow to the lower extremities.

About AIROS Medical

Founded in 2016 and headquartered in Audubon, PA, AIROS Medical specializes in the design and manufacture of innovative compression therapy systems that support individuals dealing with vascular conditions. Their commitment to improving patient care is evident in their expanding range of products, which include devices specifically for lymphedema and chronic venous insufficiency.